The recent Common Rule revision process took almost a decade and the resulting changes are fairly modest, particularly when compared to the ambitious ideas proposed in the advance notice of proposed rulemaking (ANPRM) and notice of proposed rulemaking (NPRM). Furthermore, the revision process did not even attempt to tackle any of the Common Rule subparts pertaining to vulnerable populations (i.e., pregnant women and fetuses, prisoners, children) where commentators think the rules unduly restrict important research. We believe that this was a missed opportunity to make desirable changes, and that given the usual process the next opportunity to revisit the Common Rule is unacceptably remote. In this article, we argue that the Common Rule should be regularly reassessed, with a mechanism for making substantive (and expeditious) changes. Drawing on lessons learned from the recent revision process, we make recommendations about ways to structure future attempts to maximize the ability to make timely and necessary changes.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010315PMC
http://dx.doi.org/10.1080/15265161.2017.1329478DOI Listing

Publication Analysis

Top Keywords

common rule
20
revision process
12
notice proposed
8
proposed rulemaking
8
common
5
rule
5
proposed
4
proposed process
4
process reliably
4
reliably updating
4

Similar Publications

Prevalence of metabolic syndrome and its risk factors among the government bank's employees of district Bijnor, Uttar Pradesh: A cross-sectional study.

J Family Med Prim Care

December 2024

Doctor, Ayurveda, Chaudhary Brahm Prakash Ayurved Charak Sansthan, New Delhi, India.

Background: Metabolic syndrome (MetS) involves having at least 3 out of 5 health conditions that increase the risk of cardiovascular disease, stroke, and type 2 diabetes mellitus. These conditions include increased blood pressure (BP), high blood sugar, excess body fat around the waist, and abnormal cholesterol or triglyceride levels. Each of these conditions is treatable with lifestyle changes and/or medication.

View Article and Find Full Text PDF

Introduction: The 2018 Common Rule revision intended to improve informed consent by recommending a concise key information (KI) section, yet provided little guidance about how to describe KI. We developed innovative, visual KI templates with attention to health literacy and visual design principles. We explored end users' attitudes, beliefs, and institutional policies that could affect implementing visual KI pages.

View Article and Find Full Text PDF

Commutability is where the measurement response for a reference material (RM) is the same as for an individual patient sample with the same concentration of analyte measured using two or more measurement systems. Assessment of commutability is essential when the RM is used in a calibration hierarchy or to ensure that clinical measurements are comparable across different measurement procedures and at different times. The commutability of three new Standard Reference Materials (SRMs) for determining serum total 25-hydroxyvitamin D [25(OH)D], defined as the sum of 25-hydroxyvitamin D [25(OH)D] and 25-hydroxyvitamin D [25(OH)D], was assessed through an interlaboratory study.

View Article and Find Full Text PDF

Chronic lymphocytic leukemia (CLL) is a malignancy caused by the overexpression of the anti-apoptotic protein B-cell lymphoma-2 (BCL-2), making it a critical therapeutic target. This study integrates computational screening, molecular docking, and molecular dynamics to identify and validate novel BCL-2 inhibitors from the ChEMBL database. Starting with 836 BCL-2 inhibitors, we performed ADME and Lipinski's Rule of Five (RO5) filtering, clustering, maximum common substructure (MCS) analysis, and machine learning models (Random Forest, SVM, and ANN), yielding a refined set of 124 compounds.

View Article and Find Full Text PDF

Background: It is common for individuals under the age of 65 to consult neurologists for cognitive complaints ranging from subjective cognitive issues to mood disorders that affect cognitive function. The challenge is rule out attention deficit hyperactivity disorders, other psychiatric causes, and cognitive impairment. In 2020, the Lancet Commission released a report analyzing 12 modifiable risk factors (MRFs) by age group.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!